Abich Monetary Wealth Administration LLC diminished its holdings in Johnson & Johnson (NYSE:JNJ – Free Report) by 12.8% in the course of the third quarter, in line with the corporate in its most up-to-date Kind 13F submitting with the Securities and Alternate Fee. The institutional investor owned 1,459 shares of the corporate’s inventory after promoting 214 shares in the course of the interval. Johnson & Johnson makes up 0.5% of Abich Monetary Wealth Administration LLC’s holdings, making the inventory its sixteenth largest place. Abich Monetary Wealth Administration LLC’s holdings in Johnson & Johnson have been price $236,000 as of its most up-to-date SEC submitting.
Numerous different institutional buyers and hedge funds have additionally just lately purchased and offered shares of the enterprise. Worth T Rowe Associates Inc. MD raised its holdings in shares of Johnson & Johnson by 16.8% in the course of the 1st quarter. Worth T Rowe Associates Inc. MD now owns 21,834,359 shares of the corporate’s inventory price $3,453,978,000 after buying a further 3,139,499 shares in the course of the interval. Massachusetts Monetary Providers Co. MA raised its stake in Johnson & Johnson by 10.8% in the course of the second quarter. Massachusetts Monetary Providers Co. MA now owns 18,780,645 shares of the corporate’s inventory price $2,744,979,000 after buying a further 1,831,751 shares in the course of the interval. Ameriprise Monetary Inc. grew its stake in shares of Johnson & Johnson by 5.5% within the 2nd quarter. Ameriprise Monetary Inc. now owns 14,374,397 shares of the corporate’s inventory valued at $2,100,427,000 after shopping for a further 754,200 shares in the course of the interval. Dimensional Fund Advisors LP elevated its holdings in shares of Johnson & Johnson by 16.2% in the course of the 2nd quarter. Dimensional Fund Advisors LP now owns 13,147,352 shares of the corporate’s inventory price $1,921,565,000 after shopping for a further 1,829,257 shares over the past quarter. Lastly, American Century Corporations Inc. lifted its holdings in Johnson & Johnson by 5.8% within the second quarter. American Century Corporations Inc. now owns 8,014,213 shares of the corporate’s inventory valued at $1,171,357,000 after buying a further 437,637 shares over the past quarter. 69.55% of the inventory is at the moment owned by institutional buyers and hedge funds.
Johnson & Johnson Inventory Efficiency
Shares of Johnson & Johnson inventory opened at $160.62 on Thursday. The enterprise has a 50-day easy shifting common of $163.44 and a 200-day easy shifting common of $155.32. The corporate has a debt-to-equity ratio of 0.44, a fast ratio of 0.85 and a present ratio of 1.07. Johnson & Johnson has a one yr low of $143.13 and a one yr excessive of $168.85. The corporate has a market cap of $386.56 billion, a PE ratio of 10.01, a P/E/G ratio of two.90 and a beta of 0.52.
Johnson & Johnson (NYSE:JNJ – Get Free Report) final introduced its quarterly earnings knowledge on Tuesday, October fifteenth. The corporate reported $2.42 EPS for the quarter, beating analysts’ consensus estimates of $2.21 by $0.21. The corporate had income of $22.47 billion for the quarter, in comparison with the consensus estimate of $22.17 billion. Johnson & Johnson had a web margin of 19.14% and a return on fairness of 35.46%. The corporate’s quarterly income was up 5.2% in comparison with the identical quarter final yr. Throughout the identical interval within the prior yr, the agency posted $2.66 EPS. On common, equities analysis analysts forecast that Johnson & Johnson will submit 9.94 EPS for the present fiscal yr.
Johnson & Johnson Proclaims Dividend
The agency additionally just lately disclosed a quarterly dividend, which might be paid on Tuesday, December tenth. Stockholders of file on Tuesday, November twenty sixth might be given a dividend of $1.24 per share. The ex-dividend date is Tuesday, November twenty sixth. This represents a $4.96 annualized dividend and a dividend yield of three.09%. Johnson & Johnson’s dividend payout ratio is at the moment 30.92%.
Insider Transactions at Johnson & Johnson
In different Johnson & Johnson information, VP Robert J. Decker offered 5,635 shares of the inventory in a transaction that occurred on Friday, August thirtieth. The shares have been offered at a mean value of $165.06, for a complete worth of $930,113.10. Following the transaction, the vp now straight owns 18,973 shares within the firm, valued at $3,131,683.38. This represents a 0.00 % lower of their possession of the inventory. The sale was disclosed in a doc filed with the SEC, which is accessible at this hyperlink. Company insiders personal 0.16% of the corporate’s inventory.
Analysts Set New Worth Targets
Numerous equities analysis analysts have commented on JNJ shares. TD Cowen diminished their goal value on Johnson & Johnson from $195.00 to $185.00 and set a “purchase” score on the inventory in a analysis report on Thursday, July 18th. StockNews.com raised shares of Johnson & Johnson from a “purchase” score to a “strong-buy” score in a analysis report on Saturday, September 14th. Sanford C. Bernstein lifted their value goal on shares of Johnson & Johnson from $161.00 to $171.00 in a analysis report on Thursday, July 18th. Daiwa Capital Markets minimize shares of Johnson & Johnson from an “outperform” score to a “impartial” score and lowered their value goal for the inventory from $160.00 to $150.00 in a analysis report on Tuesday, July twenty third. Lastly, Daiwa America lowered Johnson & Johnson from a “strong-buy” score to a “maintain” score in a analysis report on Tuesday, July twenty third. Six analysts have rated the inventory with a maintain score, seven have issued a purchase score and one has issued a robust purchase score to the corporate. Based on MarketBeat.com, Johnson & Johnson has a mean score of “Reasonable Purchase” and a consensus goal value of $175.93.
Examine Out Our Newest Report on JNJ
Johnson & Johnson Profile
Johnson & Johnson, along with its subsidiaries, researches, develops, manufactures, and sells numerous merchandise within the healthcare discipline worldwide. The corporate’s Modern Medication section gives merchandise for numerous therapeutic areas, equivalent to immunology, together with rheumatoid arthritis, psoriatic arthritis, inflammatory bowel illness, and psoriasis; infectious ailments comprising HIV/AIDS; neuroscience, consisting of temper issues, neurodegenerative issues, and schizophrenia; oncology, equivalent to prostate most cancers, hematologic malignancies, lung most cancers, and bladder most cancers; cardiovascular and metabolism, together with thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension by means of retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use.
Featured Tales
Need to see what different hedge funds are holding JNJ? Go to HoldingsChannel.com to get the newest 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ – Free Report).
Obtain Information & Scores for Johnson & Johnson Each day – Enter your e-mail tackle beneath to obtain a concise every day abstract of the newest information and analysts’ rankings for Johnson & Johnson and associated firms with MarketBeat.com’s FREE every day e-mail e-newsletter.
